AIM ImmunoTech

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.

CEO

Thomas Kenwood Equels

CEOThomas Kenwood Equels

Employees

Employees26

Headquarters

Ocala, Florida

HeadquartersOcala, Florida

Founded

1966

Founded1966

Employees

Employees26

AIM Key Statistics

Market cap

21.53M

Market cap21.53M

Price-Earnings ratio

-0.71

Price-Earnings ratio-0.71

Dividend yield

—

Dividend yield—

Average volume

145.73K

Average volume145.73K

High today

$0.4599

High today$0.4599

Low today

$0.4201

Low today$0.4201

Open price

$0.4399

Open price$0.4399

Volume

406.03K

Volume406.03K

52 Week high

$0.7487

52 Week high$0.7487

52 Week low

$0.3201

52 Week low$0.3201

AIM ImmunoTech

Why Robinhood?

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. Show more

AIM Key Statistics

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen.